| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $84,550 | 3 | 100 |
Sells | $0 | 0 | 0 |
| FISCHER JOST | director | 3 | $84,550 | 0 | $0 | $84,550 |
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Over the last 12 months, insiders at AEON Biopharma, Inc. have bought $84,550 and sold $0 worth of AEON Biopharma, Inc. stock.
On average, over the past 5 years, insiders at AEON Biopharma, Inc. have bought $84,550 and sold $38.29M worth of stock each year.
Highest buying activity among insiders over the last 12 months: FISCHER JOST (director) — $84,550.
The last purchase of 60,000 shares for transaction amount of $29,250 was made by FISCHER JOST (director) on 2025‑05‑21.
| 2025-05-21 | FISCHER JOST | director | 60,000 0.5653% | $0.49 | $29,250 | +36.02% | ||
| 2025-05-20 | FISCHER JOST | director | 60,000 0.5606% | $0.51 | $30,360 | +32.63% | ||
| 2025-05-19 | FISCHER JOST | director | 50,000 0.4599% | $0.50 | $24,940 | +27.83% | ||
| 2023-08-11 | Sale | Strathspey Crown Holdings Group, LLC | 10 percent owner | 7.38M – | $10.00 | $73.8M | -21.15% | |
| 2021-03-23 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 73,226 3.4019% | $10.10 | $739,583 | ||
| 2021-03-22 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 100,650 4.6993% | $10.15 | $1.02M | ||
| 2021-03-19 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 11,033 0.5176% | $10.20 | $112,537 | ||
| 2021-03-17 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 3,500 0.1642% | $10.20 | $35,700 | ||
| 2021-02-25 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 62,356 2.9686% | $10.35 | $645,385 | ||
| 2021-02-17 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 10,000 0.4899% | $10.65 | $106,500 | ||
| 2021-01-26 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 10,000 0.483% | $10.50 | $105,000 |
| Increased Positions | 5 | +7.58% | 1M | +846.79% |
| Decreased Positions | 31 | -46.97% | 73,686 | -42.24% |
| New Positions | 2 | New | 1M | New |
| Sold Out Positions | 24 | Sold Out | 73,648 | Sold Out |
| Total Postitions | 40 | -39.39% | 2M | +804.55% |
| Atalaya Capital Management Lp | $26.00 | 0.46% | 51,046 | 0 | 0% | 2024-06-30 |
| Blue Owl Capital Holdings Lp | $21.00 | 0.39% | 42,356 | -4,053 | -8.73% | 2024-12-31 |
| Polar Asset Management Partners Inc. | $19.00 | 0.35% | 38,374 | -11,629 | -23.26% | 2024-12-31 |
| Vanguard Group Inc | $5.00 | 0.1% | 10,405 | -31 | -0.3% | 2024-12-31 |
| Formidable Asset Management, Llc | $5.00 | 0.09% | 9,573 | +4,159 | +76.82% | 2024-12-31 |
| Blackrock, Inc. | $2.00 | 0.03% | 3,671 | -17 | -0.46% | 2025-03-31 |
| Ikarian Capital, Llc | $2.00 | 0.03% | 3,578 | -5 | -0.14% | 2024-12-31 |
| Geode Capital Management, Llc | $2.00 | 0.03% | 3,497 | +119 | +3.52% | 2024-12-31 |
| Bank Of America Corp /De/ | $1.00 | 0.02% | 2,314 | 0 | 0% | 2024-12-31 |
| Caprock Group, Llc | $0 | 0.01% | 871 | 0 | 0% | 2024-12-31 |